Published in Indian Pacing Electrophysiol J on April 01, 2005
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet (1999) 10.07
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med (1997) 10.02
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med (1995) 3.56
Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet (1994) 3.18
Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med (1980) 3.12
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol (1992) 3.03
Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001) 2.50
Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation (1993) 2.20
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. J Am Coll Cardiol (2003) 2.05
Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation (2002) 1.93
Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation (1996) 1.92
Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol (1989) 1.87
Survival after implantation of the cardioverter defibrillator. Am J Cardiol (1992) 1.76
Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol (2003) 1.73
Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation (1988) 1.67
Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation (1993) 1.64
Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation (2003) 1.47
Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol (1999) 1.45
Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol (1983) 1.30
Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol (1997) 1.18
QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol (1996) 1.11
Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device. Circulation (1992) 1.05
The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Ann Intern Med (1987) 1.04
Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol (1988) 1.03
Heart rate turbulence: a new predictor for risk of sudden cardiac death. Ann Noninvasive Electrocardiol (2005) 1.03
Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol (1990) 1.00
Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med (1988) 0.99
The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol (1989) 0.94
A phenomenon of heart-rate turbulence, its evaluation, and prognostic value. Card Electrophysiol Rev (2002) 0.92
Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol (2002) 0.87
Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. Am J Cardiol (1985) 0.87
Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol (2003) 0.87
Prognostic value of late potentials in patients with congestive heart failure. Eur Heart J (1996) 0.86
Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group. J Am Coll Cardiol (1992) 0.86
Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy. J Am Coll Cardiol (1999) 0.86
Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol (1994) 0.86
Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy. Heart (2000) 0.84
Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol (1998) 0.84
Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol (1986) 0.84
Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol (1996) 0.83
Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia. Am J Cardiol (1990) 0.82
Prognostic significance of heart rate variability in dilated cardiomyopathy. Int J Cardiol (2003) 0.81
Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol (1988) 0.81
Value of heart rate variability to predict ventricular arrhythmias in recipients of prophylactic defibrillators with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol (2003) 0.81
Long-term prognostic value of time domain analysis of signal-averaged electrocardiography in idiopathic dilated cardiomyopathy. Am J Cardiol (2000) 0.80
Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias. J Am Coll Cardiol (1993) 0.79
Baroreflex sensitivity and heart rate variability in coronary disease compared to dilated cardiomyopathy. Pacing Clin Electrophysiol (1998) 0.79
Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol (2003) 0.79
The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation. Am Heart J (1986) 0.79
The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol (1988) 0.78
[Idiopathic ventricular extrasystole : right ventricular parasystole not protected from the sinus rhythm?]. Arch Mal Coeur Vaiss (1981) 0.78
High gain signal averaged electrocardiogram combined with 24 hour monitoring in patients early after myocardial infarction for bedside prediction of arrhythmic events. Br Heart J (1988) 0.77
Comparison of clinical benefits and outcome in patients with programmable and nonprogrammable implantable cardioverter defibrillators. Pacing Clin Electrophysiol (1992) 0.76
Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol (2000) 0.76
Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol (2000) 0.76
Clinical usefulness of the combination of T-wave alternans and late potentials for identifying high-risk patients with moderately or severely impaired left ventricular function. Jpn Circ J (2001) 0.76
Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry. Am Heart J (2001) 0.76
The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death. Am J Cardiol (1997) 0.76
Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death. Cardiology (1996) 0.76
Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmias. Am J Cardiol (1993) 0.76
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT. Blood (2012) 1.63
Frequency-sensitive competitive learning for scalable balanced clustering on high-dimensional hyperspheres. IEEE Trans Neural Netw (2004) 1.19
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother (2007) 1.11
Japanese Encephalitis Virus infection induces IL-18 and IL-1beta in microglia and astrocytes: correlation with in vitro cytokine responsiveness of glial cells and subsequent neuronal death. J Neuroimmunol (2008) 0.99
Japanese encephalitis virus infection decrease endogenous IL-10 production: correlation with microglial activation and neuronal death. Neurosci Lett (2007) 0.97
Pak and Rac GTPases promote oncogenic KIT-induced neoplasms. J Clin Invest (2013) 0.94
Tumor necrosis factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis. Neurochem Int (2008) 0.89
The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor. Blood (2011) 0.89
Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan. J Antimicrob Chemother (2008) 0.89
Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis. Chest (2013) 0.89
Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin. Structure (2011) 0.88
The TonB dimeric crystal structures do not exist in vivo. MBio (2010) 0.88
Analysis of polymorphic residues reveals distinct enzymatic and cytotoxic activities of the Streptococcus pyogenes NAD+ glycohydrolase. J Biol Chem (2013) 0.87
p85β regulatory subunit of class IA PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis. Blood (2012) 0.87
Role of implantable cardioverter defibrillators in the treatment of hypertrophic cardiomyopathy. Indian Pacing Electrophysiol J (2005) 0.83
Isolated and significant left main coronary artery disease: demographics, hemodynamics and angiographic features. Angiology (2006) 0.82
Plasma arc curing of ceramic brackets: an evaluation of shear bond strength and debonding characteristics. Am J Orthod Dentofacial Orthop (2003) 0.81
Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure. Am J Cardiol (2012) 0.79
Prediction of left main coronary artery obstruction by 12-lead electrocardiography: ST segment deviation in lead V6 greater than or equal to ST segment deviation in lead V1. Ann Noninvasive Electrocardiol (2006) 0.78
Class I(A) PI3Kinase regulatory subunit, p85α, mediates mast cell development through regulation of growth and survival related genes. PLoS One (2012) 0.77
Torsade de Pointes due to Methadone Use in a Patient with HIV and Hepatitis C Coinfection. Cardiol Res Pract (2010) 0.77
S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance. J Clin Invest (2016) 0.77
Automated hierarchical density shaving: a robust automated clustering and visualization framework for large biological data sets. IEEE/ACM Trans Comput Biol Bioinform (2010) 0.76
Sudden cardiac death in athletes - what can be done? Indian Pacing Electrophysiol J (2006) 0.75
Comparison of two-dimensional echocardiographic tissue harmonic imaging and gated sestamibi single-photon emission computed tomographic left ventricular ejection fraction measurements. Am J Cardiol (2003) 0.75
Management of atrial fibrillation with reference to valvular heart disease. Indian Heart J (2002) 0.75
Importance of haemodynamic monitoring in cardiac tamponade. Hosp Med (2005) 0.75
gamAID: Greedy CP tensor decomposition for supervised EHR-based disease trajectory differentiation. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
The obesity paradox in ICU patients. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
Digoxin toxicity in renal failure: role of the electrocardiogram. Br J Hosp Med (Lond) (2007) 0.75
Cardiac resynchronization therapy for non-ischemic cardiomyopathy-immediate changes in QRS duration, with left bundle branch block pattern on electrocardiogram. Am Heart Hosp J (2011) 0.75
Intravenous Immunoglobulin-Induced Profound Bradycardia in a Patient With Idiopathic Thrombocytopenic Purpura. Am J Ther (2017) 0.75
Identifying candidate disease genes using a trace norm constrained bipartite raking model. Conf Proc IEEE Eng Med Biol Soc (2013) 0.75
Multivariate temporal symptomatic characterization of cardiac arrest. Conf Proc IEEE Eng Med Biol Soc (2013) 0.75
Competitive learning with pairwise constraints. IEEE Trans Neural Netw Learn Syst (2013) 0.75
Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis. Am Heart Hosp J (2010) 0.75